Compare DexCom, Inc. (DXCM) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs VanEck Junior Gold Miners — how do they compare? DexCom, Inc. trades at $83.39 (market cap $31.86B), while VanEck Junior Gold Miners trades at $114.64 (market cap $8.22B). The key difference: DexCom, Inc. is far larger — about 3.9× VanEck Junior Gold Miners's market cap, and DexCom, Inc. is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and VanEck Junior Gold Miners for 41 Days on average.
| DXCM | GDXJ | |
|---|---|---|
Market Cap | $31.86B | $8.22B |
Volume | 3,607,070 | 3,212,198 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $92.34 | $156.19 |
52-Week Low | $54.84 | $87.56 |
Typical Hold Time | 62 Days | 41 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
GDXJ, the VanEck Junior Gold Miners ETF, trades at $113.02, up 3.56% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF is undergoing significant rebalancing, with multiple junior mining companies added in September 2026, potentially increasing diversification. Key support lies at $110, with resistance at $113. Financial ratios are not applicable as this is a fund tracking an index of gold mining equities.
The outlook remains cautious due to bearish technicals, though inclusion of new holdings may attract flows. Risks include gold price volatility and mining sector operational challenges. Analyst views on constituent stocks vary, but the ETF offers exposure to small-cap gold miners, which can be high-risk, high-reward during gold rallies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
